Literature DB >> 16941183

Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis.

Daniel Sanák1, Vladimír Nosál', David Horák, Andrea Bártková, Kamil Zelenák, Roman Herzig, Jirí Bucil, David Skoloudík, Stanislav Burval, Viera Cisariková, Ivanka Vlachová, Martin Köcher, Jana Zapletalová, Egon Kurca, Petr Kanovský.   

Abstract

INTRODUCTION: Magnetic resonance imaging (MRI) may help identify acute stroke patients with a higher potential benefit from thrombolytic therapy. The aim of our study was to assess the correlation between initial cerebral infarct (CI) volume (quantified on diffusion-weighted MRI) and the resulting clinical outcome in acute stroke patients with middle cerebral artery (MCA) (M(1-2) segment) occlusion detected on MRI angiography treated by intravenous/intraarterial thrombolysis.
METHODS: Initial infarct volume (V(DWI-I) ) was retrospectively compared with neurological deficit evaluated using the NIH stroke scale on admission and 24 h later, and with the 90-day clinical outcome assessed using the modified Rankin scale in a series of 25 consecutive CI patients. The relationship between infarct volume and neurological deficit severity was assessed and, following the establishment of the maximum V(DWI-I) still associated with a good clinical outcome, the patients were divided into two groups (V(DWI-I) < or =70 ml and >70 ml).
RESULTS: V(DWI-I) ranged from 0.7 to 321 ml. The 24-h clinical outcome improved significantly (P=0.0001) in 87% of patients with a V(DWI-I) < or =70 ml (group 1) and deteriorated significantly (P=0.0018) in all patients with a V(DWI-I) >70 ml (group 2). The 90-day mortality was 0% in group 1 and 71.5% in group 2. The 90-day clinical outcome was significantly better in group 1 than in group 2 (P=0.026).
CONCLUSION: Clinical outcome could be predicted from initial infarct volume quantified by MRI-DWI in acute CI patients with MCA occlusion treated by intravenous/intraarterial thrombolysis. Patients with a V(DWI-I) < or =70 ml had a significantly better outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16941183     DOI: 10.1007/s00234-006-0105-0

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  36 in total

1.  Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain.

Authors:  P E Grant; J He; E F Halpern; O Wu; P W Schaefer; L H Schwamm; R F Budzik; A G Sorensen; W J Koroshetz; R G Gonzalez
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

2.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

3.  Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.

Authors:  Mark W Parsons; P Alan Barber; Jonathon Chalk; David G Darby; Stephen Rose; Patricia M Desmond; Richard P Gerraty; Brian M Tress; Peter M Wright; Geoffrey A Donnan; Stephen M Davis
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

4.  Normal diffusion-weighted MRI during stroke-like deficits.

Authors:  H Ay; F S Buonanno; G Rordorf; P W Schaefer; L H Schwamm; O Wu; R G Gonzalez; K Yamada; G A Sorensen; W J Koroshetz
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

5.  Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke.

Authors:  C B Grandin; T P Duprez; A M Smith; F Mataigne; A Peeters; C Oppenheim; G Cosnard
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

6.  Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection.

Authors:  G W Albers
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

7.  CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department.

Authors:  Mark E Mullins; Pamela W Schaefer; A Gregory Sorensen; Elkan F Halpern; Hakan Ay; Julian He; Walter J Koroshetz; R Gilberto Gonzalez
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

8.  Identifying thresholds for penumbra and irreversible tissue damage.

Authors:  Wolf-Dieter Heiss; Jan Sobesky; Volker Hesselmann
Journal:  Stroke       Date:  2004-09-30       Impact factor: 7.914

9.  Influence of availability of clinical history on detection of early stroke using unenhanced CT and diffusion-weighted MR imaging.

Authors:  Mark E Mullins; Michael H Lev; Dawid Schellingerhout; Walter J Koroshetz; R Gilberto Gonzalez
Journal:  AJR Am J Roentgenol       Date:  2002-07       Impact factor: 3.959

10.  Clinical experience with diffusion-weighted MR in patients with acute stroke.

Authors:  K O Lövblad; H J Laubach; A E Baird; F Curtin; G Schlaug; R R Edelman; S Warach
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

View more
  35 in total

1.  Multimodal imaging in acute ischemic stroke.

Authors:  William A Copen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 2.  Physiologic imaging in acute stroke: Patient selection.

Authors:  Clinton D Morgan; Marcus Stephens; Scott L Zuckerman; Magarya S Waitara; Peter J Morone; Michael C Dewan; J Mocco
Journal:  Interv Neuroradiol       Date:  2015-06-10       Impact factor: 1.610

Review 3.  Clinical MRI of acute ischemic stroke.

Authors:  R Gilberto González
Journal:  J Magn Reson Imaging       Date:  2012-08       Impact factor: 4.813

4.  Combining MRI with NIHSS thresholds to predict outcome in acute ischemic stroke: value for patient selection.

Authors:  P W Schaefer; B Pulli; W A Copen; J A Hirsch; T Leslie-Mazwi; L H Schwamm; O Wu; R G González; A J Yoo
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-25       Impact factor: 3.825

5.  Malignant CTA collateral profile is highly specific for large admission DWI infarct core and poor outcome in acute stroke.

Authors:  L C S Souza; A J Yoo; Z A Chaudhry; S Payabvash; A Kemmling; P W Schaefer; J A Hirsch; K L Furie; R G González; R G Nogueira; M H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

6.  Exploratory analysis of glyburide as a novel therapy for preventing brain swelling.

Authors:  Kevin N Sheth; W Taylor Kimberly; Jordan J Elm; Thomas A Kent; Albert J Yoo; Götz Thomalla; Bruce Campbell; Geoffrey A Donnan; Stephen M Davis; Gregory W Albers; Sven Jacobson; Gregory del Zoppo; J Marc Simard; Barney J Stern; Pitchaiah Mandava
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

7.  Functionalized Phenylbenzamides Inhibit Aquaporin-4 Reducing Cerebral Edema and Improving Outcome in Two Models of CNS Injury.

Authors:  George W Farr; Christopher H Hall; Susan M Farr; Ramon Wade; Joshua M Detzel; Amielia G Adams; Jasen M Buch; Derek L Beahm; Christopher A Flask; Kui Xu; Joseph C LaManna; Paul R McGuirk; Walter F Boron; Marc F Pelletier
Journal:  Neuroscience       Date:  2019-02-07       Impact factor: 3.590

8.  Acute ischemic stroke: infarct core estimation on CT angiography source images depends on CT angiography protocol.

Authors:  Benjamin Pulli; Pamela W Schaefer; Reza Hakimelahi; Zeshan A Chaudhry; Michael H Lev; Joshua A Hirsch; R Gilberto González; Albert J Yoo
Journal:  Radiology       Date:  2011-12-20       Impact factor: 11.105

9.  Imaging Biomarkers for Intra-arterial Stroke Therapy.

Authors:  Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo
Journal:  Cardiovasc Eng Technol       Date:  2013-12-01       Impact factor: 2.495

10.  MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization.

Authors:  Albert J Yoo; Luis A Verduzco; Pamela W Schaefer; Joshua A Hirsch; James D Rabinov; R Gilberto González
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.